CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Skelbimai: lankomiausias Lietuvoje pardavimo, nuomos ir kitų skelbimų portalas - Skelbiu.lt
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention - Cusabio
CD Antigens Related to Cell Activation | Sino Biological
CD40: Targeting Co-Stimulatory Pathways for Cancer Immunotherapy
Zooming in on dendritic cells for CD40 agonists | Nature Cancer
CD40 and CD40L Immune Checkpoints for Immuno-oncology Research from Adipogen Life Sciences
The CD40/CD40L costimulatory pathway in inflammatory bowel disease | Gut
model of the potential effects of agonist anti-CD40 on the T-cell... | Download Scientific Diagram
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis